ARDS Clinical Challenges

Overview

 

Acute Respiratory Distress Syndrome (ARDS) is a complex, rapid, and distinct acute respiratory failure characterized by hypoxemia, widespread inflammation in both lungs, and pulmonary edema [1][2][3]. Approximately 10.4% of patients admitted to the Intensive Care Unit (ICU) resulted in ARDS [6], and around 60-70% of COVID-19 patients admitted in ICU resulted in ARDS [8]. Although outcomes in recent years have improved, mortality rates remain high [1].

ARDS remains a problem globally

 

2M

Patients affected by ARDS globally in 2017 [4]

40%

Mortality rate for ARDS [1]

60-70%

COVID-19 patients admitted to the ICU resulted in ARDS [8]

 

Current limitations in ARDS management

 

alt text

Ventilation Mode

Low tidal volume ventilation is currently the only treatment shown to reduce mortality rates [1][2][3][5].


 

alt text

Ventilator Settings

Incorrect ventilator settings may induce more lung damage, worsening outcomes.


 

alt text

No Consensus

Research has shown that there is currently no consensus among clinicians on how to set ventilator settings for ARDS patients [7].


 

alt text

Invasive

Currently, there is no non-invasive monitoring technique to assess shunt fraction.


1. Lumb, A.B., Nunn's applied respiratory physiology eBook. 2016: Elsevier Health Sciences.

2. Coudroy, R., F. Boissier, and A.W. Thille, Acute Respiratory Distress Syndrome (ARDS): Definition, Incidence, and Outcome, in Acute Respiratory Distress Syndrome. 2017, Springer. p. 1-13.

3. Gattinoni, L., et al., Positive end-expiratory pressure: how to set it at the individual level. Annals of Translational Medicine, 2017. 5(14): p. 288.

4. Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788–800.

5. Brower, R., et al., The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000. 342(18): p. 1301-8.

6. Pham T, Rubenfeld GD. Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review. Am J Respir Crit Care Med. 2017 Apr;195(7):860-870

7. Diamond M, Peniston Feliciano HL, Sanghavi D, et al. Acute Respiratory Distress Syndrome. [Updated 2021 Jan 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/nooks/NBK436002/

8. Phua, J., Weng, L., Ling, L., Egi, M., Lim, C. M., Divatia, J. V., ... & Asian Critical Care Clinical Trials Group. (2020). Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. The Lancet Respiratory Medicine, 8(5), 506-517